With reference to his reply to question 538 on 28 April 2013, what is the breakdown in the (a) processing and (b) time frame of the Medicine Control Council for registrations in respect of the (i) 39 months for pharmaceutical entities, (ii) 26 months for new clinical indications and (iii) 18 months for new doses of already existing registered molecules?